Clinivation's Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.

Headquartered in San Diego, California, SeQual is a technology-based private company founded in 1991. The mission of SeQual is to develop, manufacture and market unique products for medical, military, industrial, and commercial applications that utilize the company's proprietary pressure swing adsorption (PSA) technology for air separation. In 1998, SeQual began focusing on developing medical oxygen concentrator devices for individuals with chronic lung disease. The company is the developer of Eclipse®2, a Personal Ambulatory Oxygen System™ (PAOS) which offers a unique design and allows patients the freedom to travel without having to carry cumbersome oxygen cylinders. SeQual recently began supplying portable oxygen concentrators to the U.S. Army. The concentrators, called the Eclipse Oxygen System, will be integrated into ambush protection vehicles that are deployed for troops' medical needs in Iraq and Afghanistan. In 2008, SeQual was rated one of America's 5000 fastest growing private companies by Inc.5000.

For more information, please visit www.sequal.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.